• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活质量受损、残疾和与慢性每日头痛相关的经济负担,重点关注伴有或不伴有药物过度使用的慢性偏头痛:系统评价。

Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review.

机构信息

Département d’Evaluation et Traitement de la Douleur Médecine Palliative, Pôle Neurosciences Cliniques, CHU de Nice-Hôpital Pasteur, 30 Avenue de la Voie Romaine, Nice cedex 1, France.

出版信息

Cephalalgia. 2011 May;31(7):837-50. doi: 10.1177/0333102411398400. Epub 2011 Apr 4.

DOI:10.1177/0333102411398400
PMID:21464078
Abstract

OBJECTIVE

To evaluate the evidence for quality of life (QoL) impairment, disability, healthcare resource use and economic burden associated with chronic daily headache (CDH), focusing on chronic migraine (CM) with or without medication overuse.

METHODS

A systematic review and qualitative synthesis of studies of patients/subjects with CDH that included CM, occurring on at least 15 days per month.

MAIN FINDINGS

Thirty-four studies were included for review (25 studies of patients and nine of subjects from the general population). CDH and CDH with medication overuse headache (MOH) were consistently associated with a lower QoL compared to control or episodic headache (EH) and CDH without MOH. CDH was consistently associated with greater disability and productivity loss, more consultations, more or longer hospitalizations and higher direct costs than EH. Data were not amenable to statistical pooling.

PRINCIPAL CONCLUSIONS

The findings of this review underline the detriment to QoL and the disabling nature of CDH, and in particular CM and CDH with MOH, and negative impact on workplace productivity compared to other types of headache.

摘要

目的

评估慢性每日头痛(CDH),尤其是慢性偏头痛(CM)伴或不伴药物过度使用相关的生活质量(QoL)受损、残疾、医疗资源使用和经济负担的证据。

方法

对包括 CM 在内的 CDH 患者/受试者研究进行系统回顾和定性综合,这些研究的头痛每月至少发生 15 天。

主要发现

共纳入 34 项研究进行综述(25 项患者研究和 9 项来自普通人群的受试者研究)。与对照或发作性头痛(EH)和无药物过度使用性头痛(MOH)的 CDH 相比,CDH 和伴有 MOH 的 CDH 始终与较低的 QoL 相关。与 EH 相比,CDH 始终与更大的残疾和生产力损失、更多的就诊次数、更多或更长时间的住院治疗以及更高的直接成本相关。数据不适于进行统计学汇总。

主要结论

本综述的研究结果强调了 QoL 的损害和 CDH 的致残性质,特别是 CM 和伴有 MOH 的 CDH,以及与其他类型头痛相比对工作场所生产力的负面影响。

相似文献

1
Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review.生活质量受损、残疾和与慢性每日头痛相关的经济负担,重点关注伴有或不伴有药物过度使用的慢性偏头痛:系统评价。
Cephalalgia. 2011 May;31(7):837-50. doi: 10.1177/0333102411398400. Epub 2011 Apr 4.
2
Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling.慢性偏头痛成人的预防性药物治疗:系统评价与经济建模。
Health Technol Assess. 2024 Oct;28(63):1-329. doi: 10.3310/AYWA5297.
3
Botulinum toxins for the prevention of migraine in adults.用于预防成人偏头痛的肉毒杆菌毒素。
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD011616. doi: 10.1002/14651858.CD011616.pub2.
4
Noninvasive Vagus Nerve Stimulation for Cluster Headache and Migraine: A Health Technology Assessment.用于丛集性头痛和偏头痛的非侵入性迷走神经刺激:一项卫生技术评估
Ont Health Technol Assess Ser. 2025 May 1;25(2):1-177. eCollection 2025.
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
Acupuncture for the prevention of episodic migraine.针刺预防发作性偏头痛
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD001218. doi: 10.1002/14651858.CD001218.pub3.
7
Psychological therapies for the management of chronic and recurrent pain in children and adolescents.用于治疗儿童和青少年慢性复发性疼痛的心理疗法。
Cochrane Database Syst Rev. 2018 Sep 29;9(9):CD003968. doi: 10.1002/14651858.CD003968.pub5.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Management of frozen shoulder: a systematic review and cost-effectiveness analysis.冻结肩的治疗:系统评价和成本效益分析。
Health Technol Assess. 2012;16(11):1-264. doi: 10.3310/hta16110.
10
Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.评估托吡酯、A型肉毒杆菌毒素和靶向降钙素基因相关肽的单克隆抗体治疗慢性偏头痛和药物过量使用性头痛患者的随机对照研究:一项系统评价和荟萃分析。
Cephalalgia. 2023 Apr;43(4):3331024231156922. doi: 10.1177/03331024231156922.

引用本文的文献

1
Burden of migraine among Egyptian people: prevalence and comorbidities.埃及人群中偏头痛的负担:患病率及合并症
J Headache Pain. 2025 May 13;26(1):114. doi: 10.1186/s10194-025-02016-0.
2
Real-World Safety and Efficacy of 156 U - 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study.156 U - 195 U 阿霉素肉毒杆菌毒素A治疗成人慢性偏头痛的真实世界安全性和有效性:REPOSE研究结果
BMC Neurol. 2025 May 6;25(1):197. doi: 10.1186/s12883-025-04087-7.
3
Real-World Insights into the Effectiveness and Tolerability of OnabotulinumtoxinA in Chronic Migraine: A Long-Term Evaluation of up to 11 Years.
关于A型肉毒毒素治疗慢性偏头痛有效性和耐受性的真实世界见解:长达11年的长期评估
Toxins (Basel). 2025 Apr 21;17(4):208. doi: 10.3390/toxins17040208.
4
Differences in pharmacological migraine treatment across different levels of clinical headache care - a cross-sectional study.不同临床头痛护理水平下偏头痛药物治疗的差异——一项横断面研究
J Headache Pain. 2025 Apr 14;26(1):78. doi: 10.1186/s10194-025-02027-x.
5
Clinical and psychological predictors of sleep quality in chronic migraine: a preliminary retrospective analysis study.慢性偏头痛患者睡眠质量的临床及心理预测因素:一项初步回顾性分析研究
BMC Neurol. 2025 Apr 11;25(1):156. doi: 10.1186/s12883-025-04165-w.
6
The Prevalence and Impact of Migraine Among Physicians in Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯医生中偏头痛的患病率及影响:一项横断面研究。
Cureus. 2024 Oct 1;16(10):e70607. doi: 10.7759/cureus.70607. eCollection 2024 Oct.
7
Chronic headaches after traumatic brain injury: Diagnostic complexity associated with increased cost.颅脑损伤后慢性头痛:诊断复杂性与费用增加相关。
NeuroRehabilitation. 2024;55(3):303-317. doi: 10.3233/NRE-230277.
8
Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review.阿托格潘与肉毒杆菌毒素A联合用于慢性偏头痛预防性治疗的安全性和有效性的真实世界证据:一项回顾性病历审查。
Pain Ther. 2024 Dec;13(6):1571-1587. doi: 10.1007/s40122-024-00649-8. Epub 2024 Sep 17.
9
Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort study.erenumab起始治疗12个月后偏头痛急性和预防性药物使用的变化:一项美国回顾性队列研究。
Headache. 2025 Jan;65(1):68-79. doi: 10.1111/head.14820. Epub 2024 Sep 9.
10
Medical comorbidities and other factors associated with migraine among individuals with diabetes mellitus in Hungary: a cross-sectional study using European Health Interview Surveys 2009-2019.匈牙利糖尿病患者偏头痛相关的合并症及其他因素:基于欧洲健康访谈调查 2009-2019 年的横断面研究
Front Endocrinol (Lausanne). 2024 Aug 23;15:1379127. doi: 10.3389/fendo.2024.1379127. eCollection 2024.